RT Journal Article
SR Electronic
T1 Use of melatonin: a single-centre audit
JF BMJ Paediatrics Open
JO BMJ Paediatrics Open
FD BMJ Publishing Group Ltd
SP e001349
DO 10.1136/bmjpo-2021-001349
VO 6
IS 1
A1 Rebecca Dack
A1 Joanna J Garstang
YR 2022
UL http://bmjpaedsopen.bmj.com/content/6/1/e001349.abstract
AB Sleep disorders in childhood are common. Melatonin is prescribed by UK community paediatricians to treat sleep disorders, but practice is not standardised. This audit reviewed melatonin prescribing within a community paediatric department in a 12-month period. 682 children received melatonin prescriptions; a random sample of 198 records were reviewed. The most common underlying condition was autism spectrum disorder (ASD) in 28%. 41% had no underlying diagnosis when melatonin was initiated and were waiting for neurodevelopmental/ASD assessment. 42% were on melatonin for at least 2 years. Further work is required to optimise melatonin prescribing practice for children and young people.